atepeq/tico19 huggingface dataset:
Combined with a serum ferritin blood test to identify cytokine storms, it is meant to counter such developments, which are thought to be the cause of death in some affected people.
V ca mat kvn thvrum pvr6tiin kv them rivm kv f66 baa k0v nvn, lust jv v la m5 mes la tussks guic, min ca diw 5 ms jvn min la n77x li11 ka naath tin moc juey.
The interleukin-6 receptor antagonist was approved by the FDA based on retrospective case studies for treatment of steroid refractory cytokine release syndrome induced by a different cause, CAR T cell therapy, in 2017.
Vn intvrkeukin-6 thieep antagonith cua jv x`th v FDA v nax rs kv jsk rvtvrsthpvktib x`c` kv tu]m yithtversdrvp0ktsr5 thaytskinla nyuuthn5 a xookv kv du]]p d]divn , kv lu`k CART th0l kv 2017.
To date, there is no randomised, controlled evidence that tocilizumab is an efficacious treatment for CRS.
V b` k` c`x walv k`, thilv kvl m5 nyooth yuth th5n, mi ca tit kv tsthilidhumab 5 gsaayv kv tu]]m CRS.
Transferring purified and concentrated antibodies produced by the immune systems of those who have recovered from COVID-19 to people who need them is being investigated as a non-vaccine method of passive immunisation.
G2r antibody k` m5 ca thiy min la tussk k` bu]m pu11ny gu11th d]divnvk` kvn tin c5 x]]th kv juey COVID-19v we k` naath tin g77r kv te naath l`tdv t`mv v la du]]p m5 /c5 ms w`l g1x ju1th kv f66 ba bu]m pu11ny jak` bit.
This strategy was tried for SARS with inconclusive results.
Vn c1p vmv cua jv f]n kv SARS k` cuv luny jsk v gsaa.
Viral neutralisation is the anticipated mechanism of action by which passive antibody therapy can mediate defence against SARS-CoV-2.
Bayrsl niwtvrslaydh22cin v jvn du]]p kvl in ca kuf]n kv vl1t min jak` antibody k` bit bv mat lat kv g1x ju1th SARS-CoV-2.
Other mechanisms however, such as antibody-dependent cellular cytotoxicity and/or phagocytosis, may be possible.
Dup k]kivn , cet kv cu]x anibody thvlulsr thaytskthit5 kvn /kiv paygothaathtith dee kvn gsw b`.
Other forms of passive antibody therapy, for example, using manufactured monoclonal antibodies, are in development.
Dup k]kivn t5 d22 antibodyn5 jak` bit kv kv , c``t, l1t kv antibody msnskslsnal in t1th n5 jv, ka dup b`.
Production of convalescent serum, which consists of the liquid portion of the blood from recovered patients and contains antibodies specific to this virus, could be increased for quicker deployment.
T1th ksnbalvthvn th5rum min te rvidv rivm m5 law-law m5 k1n kv naath tin x]]th k` te kv anibodyn5 nyin bayr`th` nvmv v civk derv gsaa kv r2p kv p0th kv l1t.
Coronavirus diseases, a group of closely related syndromes
Juey ksrsnabayr`thv bu]n m5 c``t nyuuthn5 kv
Li Wenliang, a doctor at Central Hospital of Wuhan, who later contracted and died of COVID-19 after raising awareness of the spread of the virus.
Li Wenliang, k5m k` thvntvr g1x ju1th k` Wuhan, m5 cv ben moc juey kv ksrv k` cv l5w kv COVID-19 kv ksr k` m22 cv naath l1r f66 tivt ciaax.